STAA Stock Price, Chart, Stats & News

STAAR Surgical Company
Save
1.55B
Market cap
54.75x
Current P/E
123.46x
Forward P/E
STAA chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 75.63% |
Operating margin | -33.31% |
Pretax margin | -34.36% |
Net margin | -33.60% |
Effective tax rate | 2.21% |
ROA | -17.43% |
ROE | -23.24% |
D/E | 0.11x |
Interest coverage ratio | – |
STAA valuation
P/E | 54.75x |
P/S | 3.70x |
P/B | 2.58x |
P/CF | -25.91x |
P/FCF | -22.12x |
P/OCF | -25.91x |
PEG | -0.65x |
EV multiple | -26.70x |
About
STAAR Surgical Company, along with its subsidiaries, specializes in ophthalmological solutions, focusing on the design, development, manufacturing, and commercialization of implantable lenses for vision correction, complete with the sophisticated delivery systems necessary for their implantation. A core offering is the Visian implantable Collamer lens (ICL) product line, designed to correct various visual impairments including myopia (nearsightedness), hyperopia (farsightedness), astigmatism, and presbyopia (age-related loss of near vision). Specifically, their Hyperopic ICL addresses farsightedness.
Similar securities
Based on sector and market capitalization
Report issue











